Beryl Drugs Ltd.
BSE: 524606 | Sector: Health care |
NSE: N.A. | ISIN Code: INE415H01017 |
BSE 00:00 | 28 Jun | 8.08 |
-0.40 (-4.72%) |
OPEN
8.07 |
HIGH
8.08 |
LOW
8.07 |
NSE 05:30 | 01 Jan | Beryl Drugs Ltd |
OPEN | 8.07 |
PREVIOUS CLOSE | 8.48 |
VOLUME | 1321 |
52-Week high | 19.30 |
52-Week low | 7.50 |
P/E | |
Mkt Cap.(Rs cr) | 4 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Beryl Drugs Ltd. (BERYLDRUGS) - Financial Ratios
Ratios | 2021 | 2020 | 2019 |
Debt-Equity Ratio | 0.67 | 0.56 | 0.33 |
Current Ratio | 1.16 | 1.06 | 1.32 |
Asset turnover ratio | 1.36 | 1.94 | 4.41 |
Inventory turnover ratio | 8.22 | 13.35 | 12.28 |
Debtors turnover ratio | 3.53 | 3.72 | 3.13 |
Interest Coverage ratio | 0.79 | 1.50 | 6.33 |
Operating Margin (%) | 11.64 | 8.89 | 9.80 |
Net Profit Margin (%) | -0.71 | 0.39 | 4.55 |
Return on Capital Employed (%) | 2.79 | 3.98 | 9.84 |
Return on Net Worth (%) | -1.29 | 0.66 | 8.32 |
Quick Links for Beryl Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices